Searched over 200M research papers
5 papers analyzed
Some studies suggest that sunlight exposure decreases the effectiveness of certain antibiotics and may contribute to antibiotic resistance, while other studies indicate that it can cause phototoxic responses and DNA damage.
19 papers analyzed
Sunlight significantly affects the efficacy of antibiotics used in agriculture, such as oxytetracycline and streptomycin. Research indicates that oxytetracycline's antibiotic potential dramatically decreases after 14 days of sunlight exposure, impacting its effectiveness against both Gram-negative and Gram-positive bacteria like Escherichia coli and Bacillus subtilis. In contrast, streptomycin's effectiveness is only moderately impacted by sunlight exposure over the same period. This suggests that environmental factors like sunlight can influence the longevity and efficacy of antibiotics, potentially contributing to the rise of antibiotic-resistant bacteria.
In urban wastewater treatment, sunlight combined with hydrogen peroxide (H2O2) has been shown to remove ciprofloxacin but not sulfamethoxazole. The photo-transformation of these antibiotics results in transformation products (TPs) that retain their antibacterial activity. However, the sunlight/H2O2 process does not achieve complete disinfection, as regrowth of bacteria like E. coli and Pseudomonas aeruginosa can occur after treatment. This highlights the limitations of sunlight-based treatments in fully eliminating antibiotic residues and resistant bacteria from wastewater.
Exposure to UV-B radiation (290-320 nm) can lead to the generation of singlet oxygen (1O2) by antibiotics such as cephaloridine, cephalexin, and nystatin. This singlet oxygen is responsible for the photodegradation of DNA and RNA bases, leading to potential cell damage. The combined effect of these antibiotics and UV-B radiation can cause undesirable phototoxic responses, suggesting that sunlight exposure should be avoided after the intake of photosensitive drugs. This is particularly important given the increasing levels of UV-B radiation due to ozone layer depletion.
UV irradiation can decrease the susceptibility of bacteria like Pseudomonas aeruginosa to antibiotics such as tetracycline, ciprofloxacin, and polymyxin B. This is due to the oxidative stress induced by UV exposure, which leads to the dysregulation of genes associated with antibiotic resistance. Insufficient UV radiation doses may thus result in decreased antibiotic susceptibility, posing potential threats to both environmental and human health.
Ofloxacin, a broad-spectrum antibiotic, generates reactive oxygen species (ROS) under sunlight exposure, leading to DNA damage and reduced antibacterial activity. The formation of photoproducts under UV-B radiation reduces the binding affinity of ofloxacin to bacterial DNA gyrase, attenuating its antimicrobial efficacy. This phototoxicity can also induce apoptosis in human skin cells, suggesting that patients should avoid sunlight exposure during treatment with photosensitive antibiotics like ofloxacin.
Sunlight and UV radiation can significantly impact the efficacy and safety of various antibiotics. While some antibiotics like oxytetracycline and ciprofloxacin are highly susceptible to photodegradation, others like streptomycin are less affected. Additionally, UV exposure can induce antibiotic resistance in bacteria and cause phototoxicity in human cells. These findings underscore the importance of considering environmental factors when using antibiotics, particularly in agricultural and medical settings, to mitigate the risks of reduced efficacy and increased resistance.
Most relevant research papers on this topic